462 related articles for article (PubMed ID: 2150581)
21. Comparison of contraceptive acceptability of levonorgestrel and ethinyl oestradiol administered in one three-phasic (Trionetta) and one monophasic (Neovletta) version.
Carlborg L
Contraception; 1983 May; 27(5):439-52. PubMed ID: 6349925
[TBL] [Abstract][Full Text] [Related]
22. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
[TBL] [Abstract][Full Text] [Related]
23. Comparative study on the acceptability of two modern monophasic oral contraceptive preparations: 30 microgram ethinyl estradiol combined with 150 microgram desogestrel or 75 microgram gestodene.
Zichella L; Sbrignadello C; Tomassini A; Di Lieto A; Montoneri C; Zarbo G; Mancone M; Pietrobattista P; Bertoli G; Perrone G
Adv Contracept; 1999; 15(3):191-200. PubMed ID: 11019950
[TBL] [Abstract][Full Text] [Related]
24. Phase III clinical trial with a new oral contraceptive containing 150 micrograms desogestrel and 20 micrograms ethinylestradiol.
Lammers P; op ten Berg M
Acta Obstet Gynecol Scand; 1991; 70(6):497-500. PubMed ID: 1837199
[TBL] [Abstract][Full Text] [Related]
25. Evidence that treatment with monophasic oral contraceptive formulations containing ethinylestradiol plus gestodene reduces bone resorption in young women.
Paoletti AM; Orrù M; Floris S; Mannias M; Vacca AM; Ajossa S; Guerriero S; Melis GB
Contraception; 2000 Apr; 61(4):259-63. PubMed ID: 10899481
[TBL] [Abstract][Full Text] [Related]
26. Clinical experience with a triphasic oral contraceptive.
Ulstein M; Svendsen E; Steier A; Bratt H; Fylling P; Lie S; Schiefloe A; Aaserud J
Acta Obstet Gynecol Scand; 1984; 63(3):233-6. PubMed ID: 6428157
[TBL] [Abstract][Full Text] [Related]
27. The effect on blood pressure of a monophasic oral contraceptive containing ethinylestradiol and gestodene.
Fuchs N; Düsterberg B; Weber-Diehl F; Mühe B
Contraception; 1995 Jun; 51(6):335-9. PubMed ID: 7554972
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and acceptability of two monophasic oral contraceptives containing ethinylestradiol and either desogestrel or gestodene.
Halbe HW; de Melo NR; Bahamondes L; Petracco A; Lemgruber M; de Andrade RP; da Cunha DC; Guazelli CA; Baracat EC
Eur J Contracept Reprod Health Care; 1998 Sep; 3(3):113-20. PubMed ID: 9853201
[TBL] [Abstract][Full Text] [Related]
29. Open, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 microg ethinyl estradiol and 75 microg gestodene and a 21-day regimen with 20 microg ethinyl estradiol and 150 microg desogestrel.
Endrikat J; Cronin M; Gerlinger C; Ruebig A; Schmidt W; Düsterberg B
Contraception; 2001 Sep; 64(3):201-7. PubMed ID: 11704101
[TBL] [Abstract][Full Text] [Related]
30. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R
J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
[TBL] [Abstract][Full Text] [Related]
31. Control of fertility with oral medication.
Diddle AW; Watts GF; Gardner WH; Williamson PJ
West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
[TBL] [Abstract][Full Text] [Related]
32. Shorter pill-free interval in combined oral contraceptives decreases follicular development.
Spona J; Elstein M; Feichtinger W; Sullivan H; Lüdicke F; Müller U; Düsterberg B
Contraception; 1996 Aug; 54(2):71-7. PubMed ID: 8842582
[TBL] [Abstract][Full Text] [Related]
33. Five-year, multicenter study of a triphasic, low-dose, combination oral contraceptive.
Woutersz TB; Korba VD
Int J Fertil; 1988; 33(6):406-10. PubMed ID: 2906915
[TBL] [Abstract][Full Text] [Related]
34. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
Cianci A; De Leo V
Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
[TBL] [Abstract][Full Text] [Related]
35. Effect of four combined oral contraceptives on blood pressure in the pill-free interval.
Nichols M; Robinson G; Bounds W; Newman B; Guillebaud J
Contraception; 1993 Apr; 47(4):367-76. PubMed ID: 8508666
[TBL] [Abstract][Full Text] [Related]
36. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
Crook D; Godsland IF; Worthington M; Felton CV; Proudler AJ; Stevenson JC
Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183
[TBL] [Abstract][Full Text] [Related]
37. Comparative metabolic effects of three types of combined oral contraceptive pills in Chinese women.
Prasad RN; Liew D; Ratnam SS
Contraception; 1989 Jan; 39(1):21-35. PubMed ID: 2521321
[TBL] [Abstract][Full Text] [Related]
38. Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation.
Elomaa K; Rolland R; Brosens I; Moorrees M; Deprest J; Tuominen J; Lähteenmäki P
Am J Obstet Gynecol; 1998 Jul; 179(1):41-6. PubMed ID: 9704763
[TBL] [Abstract][Full Text] [Related]
39. Progestogen-only microdose followed by estrogen-progestogen combination, a new approach to oral contraception.
Russowsky M; Sartoretto JN
Contraception; 1982 Jul; 26(1):41-9. PubMed ID: 7128133
[TBL] [Abstract][Full Text] [Related]
40. Desogestrel, norgestimate, and gestodene: the newer progestins.
Kaplan B
Ann Pharmacother; 1995; 29(7-8):736-42. PubMed ID: 8520092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
